Nimmanon, Thirayost
Ziliotto, Silvia
Ogle, Olivia
Burt, Anna
Gee, Julia M. W.
Andrews, Glen K.
Kille, Pete
Hogstrand, Christer
Maret, Wolfgang
Taylor, Kathryn M. http://orcid.org/0000-0002-9576-9490
Funding for this research was provided by:
Wellcome Trust (091991/Z/10/Z)
Tenovus (PhD 2015/L31)
Life sciences research network wales
Article History
Received: 12 February 2020
Revised: 22 July 2020
Accepted: 7 August 2020
First Online: 14 August 2020
Compliance with ethical standards
:
: KMT is a named inventor on a patent describing the use of ZIP6 and ZIP10 antibodies to inhibit mitosis and stands to gain from the development. All other authors declare no conflictof interest.